Evidence map›Paper›PMID 41146320›Full record

ArticleBMC research notes2025

Impact of HLD6-associated TUBB4A mutant proteins on cell morphogenesis.

Yuki Kasamatsu, Mei Tanaka, Minori Minegishi, Yuki Miyamoto, Junji Yamauchi

Abstract read
In one paragraph

Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuki KasamatsuLaboratory of Molecular Neurology, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Mei TanakaLaboratory of Molecular Neurology, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Minori MinegishiLaboratory of Molecular Neurology, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Yuki MiyamotoLaboratory of Molecular Neurology, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Junji YamauchiLaboratory of Molecular Neurology, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan. yamauchi@toyaku.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oligodendroglial cells are a type of glial cell in the central nervous system (CNS) that surround neuronal axons with a specialized cell membrane called the myelin sheath. Their physiological functions and their functional defects in pathological conditions have been well studied so far. However, the molecular mechanisms that control oligodendroglial cell differentiation and its destruction remain unclear. In oligodendroglial diseases such as congenital hypomyelinating leukodystrophies, differentiation often appears to be arrested at an immature stage. Here, for the first time, we report that hypomyelinating leukodystrophy type 6 (HLD6)-associated tubulin beta 4 A (TUBB4A) mutated proteins (6 types of missense mutations), but not the wild type one, disrupt the cell morphological changes with myelin sheath-like widespread membranes in FBD-102b cells, a mouse oligodendroglial model undergoing differentiation. Consistently, expression levels of oligodendroglial cell differentiation marker proteins and Akt kinase phosphorylation, a key signaling pathway promoting oligodendroglial differentiation and myelination, were reduced. Notably, mutated TUBB4A proteins failed to undergo the proper post-translational processing necessary for microtubule formation. Instead, these proteins localized aberrantly to intracellular organelle-like structures. These findings suggest that HLD6-asociated TUBB4A mutations lead to defective cell morphogenesis, providing novel insights into the pathological molecular mechanisms underlying differentiation arrest before myelination, at least at the molecular and cellular levels.

Indexed as

MorphogenesisOligodendrogliaTubulinAnimalsCell DifferentiationCell LineHumansMiceMicrotubulesMutation, MissenseMyelin SheathTUBB4A protein, humanTubulinDifferentiation before myelinationHLD6MicrotubuleOligodendrocyteTUBB4A

Identifiers

PMID41146320
PMCPMC12560304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.